Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-12

Clinical Trial Update: Cluster Headache Treatment With Rimegepant [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating rimegepant for cluster headaches has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

Sponsor: Mayo Clinic | Conditions: Cluster Headache | Phase 2 | Status: COMPLETED